BIDMC launches clinical trials evaluating anti-viral drug remdesivir for COVID-19

Boston, Mass. – Physician-scientists at Beth Israel Deaconess Medical Center (BIDMC) are now enrolling patients in two clinical trials testing treatment options for COVID-19, the illness caused by the novel coronavirus. Two trials, led by infectious disease specialist Kathryn Stephenson, MD, MPH, will test the antiviral drug remdesivir for safety and efficacy against the respiratory…

Details

Bentham Science announces new multidisciplinary journal, ‘Current Chinese Science’

Bentham Science announces an important new multidisciplinary journal, Current Chinese Science. This will be the world’s largest journal with over 4,000 leading Chinese scientists involved on its editorial board. Current Chinese Science is a peer reviewed journal with over 70 sections headed by leading Chinese scientists as Co-Editors. The journal will cover important and emerging…

Details

Older people generally more emotionally healthy, better able to resist daily temptations

DURHAM, NC — The stereotype of grumpy old people apparently doesn’t hold up under closer inspection. A new study from Duke and Vanderbilt University psychologists finds that older people are generally more emotionally stable and better able to resist temptations in their daily lives. “There is evidence here that emotional health and regulation improve…

Details

In COVID-19 response to Congress, AGS calls for medical supplies, telehealth

In letters sent yesterday to Congressional leaders, Vice President Pence, and White House Coronavirus Task Force Coordinator Deborah Birx, MD, experts at the American Geriatrics Society (AGS) reinforced the need for medical supplies, telehealth, expertise in older adult care, and a range of other priorities in response to COVID-19. As diverse as these important focal…

Details

Rheumatology group launches registry to get COVID-19 data on rheumatic disease patients

SAN FRANCISCO – Today, the COVID-19 Global Rheumatology Alliance launched an international registry to help collect data that will be used to guide rheumatology clinicians and health professionals as they assess and treat rheumatic disease patients who are, or may become, infected with the SARS-CoV-2 virus that causes COVID-19. The registry will also evaluate the…

Details